Actuate Therapeutics, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | – | – | |
| – | -35.2% | +371.2% | +203.0% | |
| – | +48.6% | -57.2% | -376.8% | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | -100.0% | |
| – | -78.5% | +565.8% | -13.8% | |
| – | -1,296.8% | – | -20.5% | |
| – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.